nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—lung cancer	0.172	0.529	CbGaD
Etodolac—ALB—lung cancer	0.154	0.471	CbGaD
Etodolac—UGT1A9—Irinotecan—lung cancer	0.0738	0.215	CbGbCtD
Etodolac—ALB—Gefitinib—lung cancer	0.0429	0.125	CbGbCtD
Etodolac—PTGS2—Cisplatin—lung cancer	0.0296	0.0864	CbGbCtD
Etodolac—PTGS2—Etoposide—lung cancer	0.0291	0.0849	CbGbCtD
Etodolac—ALB—Erlotinib—lung cancer	0.0254	0.074	CbGbCtD
Etodolac—PTGS1—Etoposide—lung cancer	0.0246	0.0717	CbGbCtD
Etodolac—CYP2C9—Gefitinib—lung cancer	0.0231	0.0675	CbGbCtD
Etodolac—ALB—Irinotecan—lung cancer	0.0229	0.0668	CbGbCtD
Etodolac—CYP2C9—Teniposide—lung cancer	0.0224	0.0654	CbGbCtD
Etodolac—SLC22A6—Methotrexate—lung cancer	0.0142	0.0415	CbGbCtD
Etodolac—CYP2C9—Paclitaxel—lung cancer	0.0125	0.0365	CbGbCtD
Etodolac—ALB—Methotrexate—lung cancer	0.0121	0.0354	CbGbCtD
Etodolac—CYP2C9—Cisplatin—lung cancer	0.0101	0.0294	CbGbCtD
Etodolac—Paraesthesia—Etoposide—lung cancer	8.21e-05	0.000432	CcSEcCtD
Etodolac—Haematuria—Methotrexate—lung cancer	8.19e-05	0.000431	CcSEcCtD
Etodolac—Loss of consciousness—Docetaxel—lung cancer	8.18e-05	0.000431	CcSEcCtD
Etodolac—Pancreatitis—Doxorubicin—lung cancer	8.18e-05	0.00043	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Paclitaxel—lung cancer	8.17e-05	0.00043	CcSEcCtD
Etodolac—Dyspnoea—Etoposide—lung cancer	8.15e-05	0.000429	CcSEcCtD
Etodolac—Somnolence—Etoposide—lung cancer	8.13e-05	0.000428	CcSEcCtD
Etodolac—Insomnia—Paclitaxel—lung cancer	8.11e-05	0.000427	CcSEcCtD
Etodolac—Hypersensitivity—Irinotecan—lung cancer	8.1e-05	0.000426	CcSEcCtD
Etodolac—Convulsion—Docetaxel—lung cancer	8.07e-05	0.000425	CcSEcCtD
Etodolac—Paraesthesia—Paclitaxel—lung cancer	8.05e-05	0.000424	CcSEcCtD
Etodolac—Hypertension—Docetaxel—lung cancer	8.04e-05	0.000423	CcSEcCtD
Etodolac—Bronchitis—Doxorubicin—lung cancer	8.02e-05	0.000422	CcSEcCtD
Etodolac—Agranulocytosis—Methotrexate—lung cancer	8.01e-05	0.000422	CcSEcCtD
Etodolac—Dyspnoea—Paclitaxel—lung cancer	7.99e-05	0.000421	CcSEcCtD
Etodolac—Somnolence—Paclitaxel—lung cancer	7.97e-05	0.00042	CcSEcCtD
Etodolac—Decreased appetite—Etoposide—lung cancer	7.95e-05	0.000418	CcSEcCtD
Etodolac—Myalgia—Docetaxel—lung cancer	7.93e-05	0.000417	CcSEcCtD
Etodolac—Arthralgia—Docetaxel—lung cancer	7.93e-05	0.000417	CcSEcCtD
Etodolac—Pancytopenia—Doxorubicin—lung cancer	7.92e-05	0.000417	CcSEcCtD
Etodolac—Nausea—Vinorelbine—lung cancer	7.92e-05	0.000417	CcSEcCtD
Etodolac—Dyspepsia—Paclitaxel—lung cancer	7.89e-05	0.000415	CcSEcCtD
Etodolac—Body temperature increased—Cisplatin—lung cancer	7.89e-05	0.000415	CcSEcCtD
Etodolac—Asthenia—Irinotecan—lung cancer	7.89e-05	0.000415	CcSEcCtD
Etodolac—Fatigue—Etoposide—lung cancer	7.88e-05	0.000415	CcSEcCtD
Etodolac—Pain—Etoposide—lung cancer	7.82e-05	0.000412	CcSEcCtD
Etodolac—Constipation—Etoposide—lung cancer	7.82e-05	0.000412	CcSEcCtD
Etodolac—Dysuria—Doxorubicin—lung cancer	7.8e-05	0.000411	CcSEcCtD
Etodolac—Neutropenia—Doxorubicin—lung cancer	7.8e-05	0.000411	CcSEcCtD
Etodolac—Decreased appetite—Paclitaxel—lung cancer	7.79e-05	0.00041	CcSEcCtD
Etodolac—Dry mouth—Docetaxel—lung cancer	7.75e-05	0.000408	CcSEcCtD
Etodolac—Haemoglobin—Methotrexate—lung cancer	7.75e-05	0.000408	CcSEcCtD
Etodolac—Fatigue—Paclitaxel—lung cancer	7.73e-05	0.000407	CcSEcCtD
Etodolac—Haemorrhage—Methotrexate—lung cancer	7.71e-05	0.000406	CcSEcCtD
Etodolac—Hepatitis—Methotrexate—lung cancer	7.71e-05	0.000406	CcSEcCtD
Etodolac—Pollakiuria—Doxorubicin—lung cancer	7.7e-05	0.000406	CcSEcCtD
Etodolac—Asthenia—Gemcitabine—lung cancer	7.68e-05	0.000404	CcSEcCtD
Etodolac—Pain—Paclitaxel—lung cancer	7.67e-05	0.000404	CcSEcCtD
Etodolac—Constipation—Paclitaxel—lung cancer	7.67e-05	0.000404	CcSEcCtD
Etodolac—Confusional state—Docetaxel—lung cancer	7.66e-05	0.000403	CcSEcCtD
Etodolac—Pharyngitis—Methotrexate—lung cancer	7.65e-05	0.000403	CcSEcCtD
Etodolac—Photosensitivity reaction—Doxorubicin—lung cancer	7.61e-05	0.000401	CcSEcCtD
Etodolac—Anaphylactic shock—Docetaxel—lung cancer	7.6e-05	0.0004	CcSEcCtD
Etodolac—Oedema—Docetaxel—lung cancer	7.6e-05	0.0004	CcSEcCtD
Etodolac—Pruritus—Gemcitabine—lung cancer	7.58e-05	0.000399	CcSEcCtD
Etodolac—Infection—Docetaxel—lung cancer	7.55e-05	0.000397	CcSEcCtD
Etodolac—Feeling abnormal—Etoposide—lung cancer	7.54e-05	0.000397	CcSEcCtD
Etodolac—Hyperglycaemia—Doxorubicin—lung cancer	7.52e-05	0.000396	CcSEcCtD
Etodolac—Diarrhoea—Irinotecan—lung cancer	7.52e-05	0.000396	CcSEcCtD
Etodolac—Pneumonia—Doxorubicin—lung cancer	7.48e-05	0.000394	CcSEcCtD
Etodolac—Gastrointestinal pain—Etoposide—lung cancer	7.48e-05	0.000394	CcSEcCtD
Etodolac—Shock—Docetaxel—lung cancer	7.48e-05	0.000394	CcSEcCtD
Etodolac—Thrombocytopenia—Docetaxel—lung cancer	7.44e-05	0.000392	CcSEcCtD
Etodolac—Visual impairment—Methotrexate—lung cancer	7.43e-05	0.000391	CcSEcCtD
Etodolac—Tachycardia—Docetaxel—lung cancer	7.42e-05	0.00039	CcSEcCtD
Etodolac—Feeling abnormal—Paclitaxel—lung cancer	7.39e-05	0.000389	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.37e-05	0.000388	CcSEcCtD
Etodolac—Hypersensitivity—Cisplatin—lung cancer	7.35e-05	0.000387	CcSEcCtD
Etodolac—Gastrointestinal pain—Paclitaxel—lung cancer	7.33e-05	0.000386	CcSEcCtD
Etodolac—Diarrhoea—Gemcitabine—lung cancer	7.33e-05	0.000386	CcSEcCtD
Etodolac—Renal failure—Doxorubicin—lung cancer	7.31e-05	0.000385	CcSEcCtD
Etodolac—Erythema multiforme—Methotrexate—lung cancer	7.29e-05	0.000384	CcSEcCtD
Etodolac—Dizziness—Irinotecan—lung cancer	7.27e-05	0.000383	CcSEcCtD
Etodolac—Urticaria—Etoposide—lung cancer	7.26e-05	0.000382	CcSEcCtD
Etodolac—Stomatitis—Doxorubicin—lung cancer	7.25e-05	0.000382	CcSEcCtD
Etodolac—Jaundice—Doxorubicin—lung cancer	7.25e-05	0.000382	CcSEcCtD
Etodolac—Anorexia—Docetaxel—lung cancer	7.24e-05	0.000381	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—lung cancer	7.23e-05	0.000381	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—lung cancer	7.23e-05	0.000381	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—lung cancer	7.23e-05	0.000381	CcSEcCtD
Etodolac—Tinnitus—Methotrexate—lung cancer	7.19e-05	0.000378	CcSEcCtD
Etodolac—Asthenia—Cisplatin—lung cancer	7.16e-05	0.000377	CcSEcCtD
Etodolac—Sweating—Doxorubicin—lung cancer	7.13e-05	0.000375	CcSEcCtD
Etodolac—Urticaria—Paclitaxel—lung cancer	7.12e-05	0.000375	CcSEcCtD
Etodolac—Hypotension—Docetaxel—lung cancer	7.1e-05	0.000374	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—lung cancer	7.09e-05	0.000373	CcSEcCtD
Etodolac—Abdominal pain—Paclitaxel—lung cancer	7.09e-05	0.000373	CcSEcCtD
Etodolac—Body temperature increased—Paclitaxel—lung cancer	7.09e-05	0.000373	CcSEcCtD
Etodolac—Vomiting—Irinotecan—lung cancer	6.99e-05	0.000368	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—lung cancer	6.98e-05	0.000367	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—lung cancer	6.94e-05	0.000365	CcSEcCtD
Etodolac—Rash—Irinotecan—lung cancer	6.93e-05	0.000365	CcSEcCtD
Etodolac—Dermatitis—Irinotecan—lung cancer	6.92e-05	0.000365	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Docetaxel—lung cancer	6.92e-05	0.000364	CcSEcCtD
Etodolac—Chills—Methotrexate—lung cancer	6.92e-05	0.000364	CcSEcCtD
Etodolac—Headache—Irinotecan—lung cancer	6.89e-05	0.000363	CcSEcCtD
Etodolac—Insomnia—Docetaxel—lung cancer	6.87e-05	0.000362	CcSEcCtD
Etodolac—Diarrhoea—Cisplatin—lung cancer	6.83e-05	0.00036	CcSEcCtD
Etodolac—Paraesthesia—Docetaxel—lung cancer	6.82e-05	0.000359	CcSEcCtD
Etodolac—Alopecia—Methotrexate—lung cancer	6.81e-05	0.000359	CcSEcCtD
Etodolac—Vomiting—Gemcitabine—lung cancer	6.81e-05	0.000358	CcSEcCtD
Etodolac—Dyspnoea—Docetaxel—lung cancer	6.77e-05	0.000357	CcSEcCtD
Etodolac—Somnolence—Docetaxel—lung cancer	6.76e-05	0.000356	CcSEcCtD
Etodolac—Rash—Gemcitabine—lung cancer	6.75e-05	0.000355	CcSEcCtD
Etodolac—Dermatitis—Gemcitabine—lung cancer	6.75e-05	0.000355	CcSEcCtD
Etodolac—Hypersensitivity—Etoposide—lung cancer	6.74e-05	0.000355	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—lung cancer	6.71e-05	0.000353	CcSEcCtD
Etodolac—Headache—Gemcitabine—lung cancer	6.71e-05	0.000353	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—lung cancer	6.69e-05	0.000352	CcSEcCtD
Etodolac—Dyspepsia—Docetaxel—lung cancer	6.69e-05	0.000352	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—lung cancer	6.68e-05	0.000351	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—lung cancer	6.68e-05	0.000351	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—lung cancer	6.63e-05	0.000349	CcSEcCtD
Etodolac—Decreased appetite—Docetaxel—lung cancer	6.61e-05	0.000348	CcSEcCtD
Etodolac—Hypersensitivity—Paclitaxel—lung cancer	6.61e-05	0.000348	CcSEcCtD
Etodolac—Dysgeusia—Methotrexate—lung cancer	6.57e-05	0.000346	CcSEcCtD
Etodolac—Asthenia—Etoposide—lung cancer	6.56e-05	0.000345	CcSEcCtD
Etodolac—Fatigue—Docetaxel—lung cancer	6.55e-05	0.000345	CcSEcCtD
Etodolac—Nausea—Irinotecan—lung cancer	6.53e-05	0.000344	CcSEcCtD
Etodolac—Pain—Docetaxel—lung cancer	6.5e-05	0.000342	CcSEcCtD
Etodolac—Constipation—Docetaxel—lung cancer	6.5e-05	0.000342	CcSEcCtD
Etodolac—Pruritus—Etoposide—lung cancer	6.47e-05	0.000341	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—lung cancer	6.43e-05	0.000339	CcSEcCtD
Etodolac—Asthenia—Paclitaxel—lung cancer	6.43e-05	0.000339	CcSEcCtD
Etodolac—Nausea—Gemcitabine—lung cancer	6.36e-05	0.000335	CcSEcCtD
Etodolac—Vomiting—Cisplatin—lung cancer	6.35e-05	0.000334	CcSEcCtD
Etodolac—Pruritus—Paclitaxel—lung cancer	6.34e-05	0.000334	CcSEcCtD
Etodolac—Vision blurred—Methotrexate—lung cancer	6.32e-05	0.000333	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—lung cancer	6.31e-05	0.000332	CcSEcCtD
Etodolac—Rash—Cisplatin—lung cancer	6.29e-05	0.000331	CcSEcCtD
Etodolac—Dermatitis—Cisplatin—lung cancer	6.29e-05	0.000331	CcSEcCtD
Etodolac—Feeling abnormal—Docetaxel—lung cancer	6.26e-05	0.00033	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—lung cancer	6.26e-05	0.000329	CcSEcCtD
Etodolac—Ill-defined disorder—Methotrexate—lung cancer	6.23e-05	0.000328	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—lung cancer	6.22e-05	0.000328	CcSEcCtD
Etodolac—Gastrointestinal pain—Docetaxel—lung cancer	6.21e-05	0.000327	CcSEcCtD
Etodolac—Anaemia—Methotrexate—lung cancer	6.2e-05	0.000327	CcSEcCtD
Etodolac—Flushing—Doxorubicin—lung cancer	6.2e-05	0.000326	CcSEcCtD
Etodolac—Diarrhoea—Paclitaxel—lung cancer	6.13e-05	0.000323	CcSEcCtD
Etodolac—Malaise—Methotrexate—lung cancer	6.05e-05	0.000319	CcSEcCtD
Etodolac—Dizziness—Etoposide—lung cancer	6.05e-05	0.000318	CcSEcCtD
Etodolac—Vertigo—Methotrexate—lung cancer	6.03e-05	0.000317	CcSEcCtD
Etodolac—Abdominal pain—Docetaxel—lung cancer	6.01e-05	0.000316	CcSEcCtD
Etodolac—Body temperature increased—Docetaxel—lung cancer	6.01e-05	0.000316	CcSEcCtD
Etodolac—Leukopenia—Methotrexate—lung cancer	6.01e-05	0.000316	CcSEcCtD
Etodolac—Chills—Doxorubicin—lung cancer	5.99e-05	0.000315	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—lung cancer	5.96e-05	0.000314	CcSEcCtD
Etodolac—Dizziness—Paclitaxel—lung cancer	5.93e-05	0.000312	CcSEcCtD
Etodolac—Nausea—Cisplatin—lung cancer	5.93e-05	0.000312	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—lung cancer	5.9e-05	0.000311	CcSEcCtD
Etodolac—Convulsion—Methotrexate—lung cancer	5.81e-05	0.000306	CcSEcCtD
Etodolac—Vomiting—Etoposide—lung cancer	5.81e-05	0.000306	CcSEcCtD
Etodolac—Rash—Etoposide—lung cancer	5.77e-05	0.000304	CcSEcCtD
Etodolac—Dermatitis—Etoposide—lung cancer	5.76e-05	0.000303	CcSEcCtD
Etodolac—Headache—Etoposide—lung cancer	5.73e-05	0.000302	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—lung cancer	5.73e-05	0.000301	CcSEcCtD
Etodolac—Arthralgia—Methotrexate—lung cancer	5.71e-05	0.000301	CcSEcCtD
Etodolac—Myalgia—Methotrexate—lung cancer	5.71e-05	0.000301	CcSEcCtD
Etodolac—Tension—Doxorubicin—lung cancer	5.7e-05	0.0003	CcSEcCtD
Etodolac—Vomiting—Paclitaxel—lung cancer	5.7e-05	0.0003	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—lung cancer	5.69e-05	0.0003	CcSEcCtD
Etodolac—Rash—Paclitaxel—lung cancer	5.65e-05	0.000298	CcSEcCtD
Etodolac—Dermatitis—Paclitaxel—lung cancer	5.65e-05	0.000297	CcSEcCtD
Etodolac—Discomfort—Methotrexate—lung cancer	5.64e-05	0.000297	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—lung cancer	5.64e-05	0.000297	CcSEcCtD
Etodolac—Headache—Paclitaxel—lung cancer	5.62e-05	0.000296	CcSEcCtD
Etodolac—Hypersensitivity—Docetaxel—lung cancer	5.6e-05	0.000295	CcSEcCtD
Etodolac—Confusional state—Methotrexate—lung cancer	5.52e-05	0.000291	CcSEcCtD
Etodolac—Anaphylactic shock—Methotrexate—lung cancer	5.48e-05	0.000288	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—lung cancer	5.48e-05	0.000288	CcSEcCtD
Etodolac—Asthenia—Docetaxel—lung cancer	5.45e-05	0.000287	CcSEcCtD
Etodolac—Infection—Methotrexate—lung cancer	5.44e-05	0.000286	CcSEcCtD
Etodolac—Nausea—Etoposide—lung cancer	5.43e-05	0.000286	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—lung cancer	5.39e-05	0.000284	CcSEcCtD
Etodolac—Pruritus—Docetaxel—lung cancer	5.38e-05	0.000283	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—lung cancer	5.37e-05	0.000283	CcSEcCtD
Etodolac—Thrombocytopenia—Methotrexate—lung cancer	5.36e-05	0.000282	CcSEcCtD
Etodolac—Nausea—Paclitaxel—lung cancer	5.33e-05	0.00028	CcSEcCtD
Etodolac—Hyperhidrosis—Methotrexate—lung cancer	5.29e-05	0.000279	CcSEcCtD
Etodolac—Malaise—Doxorubicin—lung cancer	5.24e-05	0.000276	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—lung cancer	5.22e-05	0.000275	CcSEcCtD
Etodolac—Anorexia—Methotrexate—lung cancer	5.22e-05	0.000275	CcSEcCtD
Etodolac—Syncope—Doxorubicin—lung cancer	5.21e-05	0.000274	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—lung cancer	5.2e-05	0.000274	CcSEcCtD
Etodolac—Diarrhoea—Docetaxel—lung cancer	5.2e-05	0.000274	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—lung cancer	5.14e-05	0.00027	CcSEcCtD
Etodolac—Hypotension—Methotrexate—lung cancer	5.12e-05	0.000269	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—lung cancer	5.11e-05	0.000269	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—lung cancer	5.03e-05	0.000265	CcSEcCtD
Etodolac—Dizziness—Docetaxel—lung cancer	5.03e-05	0.000265	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—lung cancer	5.02e-05	0.000264	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Methotrexate—lung cancer	4.99e-05	0.000263	CcSEcCtD
Etodolac—Insomnia—Methotrexate—lung cancer	4.95e-05	0.000261	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—lung cancer	4.95e-05	0.00026	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—lung cancer	4.95e-05	0.00026	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—lung cancer	4.93e-05	0.00026	CcSEcCtD
Etodolac—Paraesthesia—Methotrexate—lung cancer	4.92e-05	0.000259	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—lung cancer	4.89e-05	0.000257	CcSEcCtD
Etodolac—Dyspnoea—Methotrexate—lung cancer	4.88e-05	0.000257	CcSEcCtD
Etodolac—Somnolence—Methotrexate—lung cancer	4.87e-05	0.000256	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—lung cancer	4.84e-05	0.000255	CcSEcCtD
Etodolac—Vomiting—Docetaxel—lung cancer	4.83e-05	0.000254	CcSEcCtD
Etodolac—Dyspepsia—Methotrexate—lung cancer	4.82e-05	0.000254	CcSEcCtD
Etodolac—Rash—Docetaxel—lung cancer	4.79e-05	0.000252	CcSEcCtD
Etodolac—Dermatitis—Docetaxel—lung cancer	4.79e-05	0.000252	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—lung cancer	4.78e-05	0.000252	CcSEcCtD
Etodolac—Decreased appetite—Methotrexate—lung cancer	4.76e-05	0.000251	CcSEcCtD
Etodolac—Headache—Docetaxel—lung cancer	4.76e-05	0.000251	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—lung cancer	4.74e-05	0.00025	CcSEcCtD
Etodolac—Oedema—Doxorubicin—lung cancer	4.74e-05	0.00025	CcSEcCtD
Etodolac—Fatigue—Methotrexate—lung cancer	4.72e-05	0.000249	CcSEcCtD
Etodolac—Infection—Doxorubicin—lung cancer	4.71e-05	0.000248	CcSEcCtD
Etodolac—Pain—Methotrexate—lung cancer	4.68e-05	0.000247	CcSEcCtD
Etodolac—Shock—Doxorubicin—lung cancer	4.67e-05	0.000246	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—lung cancer	4.64e-05	0.000244	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—lung cancer	4.63e-05	0.000244	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—lung cancer	4.58e-05	0.000241	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—lung cancer	4.52e-05	0.000238	CcSEcCtD
Etodolac—Nausea—Docetaxel—lung cancer	4.51e-05	0.000238	CcSEcCtD
Etodolac—Feeling abnormal—Methotrexate—lung cancer	4.51e-05	0.000238	CcSEcCtD
Etodolac—Gastrointestinal pain—Methotrexate—lung cancer	4.48e-05	0.000236	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—lung cancer	4.43e-05	0.000233	CcSEcCtD
Etodolac—Urticaria—Methotrexate—lung cancer	4.35e-05	0.000229	CcSEcCtD
Etodolac—Abdominal pain—Methotrexate—lung cancer	4.33e-05	0.000228	CcSEcCtD
Etodolac—Body temperature increased—Methotrexate—lung cancer	4.33e-05	0.000228	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.32e-05	0.000227	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—lung cancer	4.29e-05	0.000226	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—lung cancer	4.26e-05	0.000224	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—lung cancer	4.23e-05	0.000223	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—lung cancer	4.22e-05	0.000222	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—lung cancer	4.17e-05	0.00022	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—lung cancer	4.12e-05	0.000217	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—lung cancer	4.09e-05	0.000215	CcSEcCtD
Etodolac—Pain—Doxorubicin—lung cancer	4.06e-05	0.000214	CcSEcCtD
Etodolac—Constipation—Doxorubicin—lung cancer	4.06e-05	0.000214	CcSEcCtD
Etodolac—Hypersensitivity—Methotrexate—lung cancer	4.04e-05	0.000212	CcSEcCtD
Etodolac—Asthenia—Methotrexate—lung cancer	3.93e-05	0.000207	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—lung cancer	3.91e-05	0.000206	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—lung cancer	3.88e-05	0.000204	CcSEcCtD
Etodolac—Pruritus—Methotrexate—lung cancer	3.88e-05	0.000204	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—lung cancer	3.77e-05	0.000198	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—lung cancer	3.75e-05	0.000197	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—lung cancer	3.75e-05	0.000197	CcSEcCtD
Etodolac—Diarrhoea—Methotrexate—lung cancer	3.75e-05	0.000197	CcSEcCtD
Etodolac—Dizziness—Methotrexate—lung cancer	3.62e-05	0.000191	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—lung cancer	3.49e-05	0.000184	CcSEcCtD
Etodolac—Vomiting—Methotrexate—lung cancer	3.48e-05	0.000183	CcSEcCtD
Etodolac—Rash—Methotrexate—lung cancer	3.45e-05	0.000182	CcSEcCtD
Etodolac—Dermatitis—Methotrexate—lung cancer	3.45e-05	0.000182	CcSEcCtD
Etodolac—Headache—Methotrexate—lung cancer	3.43e-05	0.000181	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—lung cancer	3.4e-05	0.000179	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—lung cancer	3.36e-05	0.000177	CcSEcCtD
Etodolac—Nausea—Methotrexate—lung cancer	3.25e-05	0.000171	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—lung cancer	3.24e-05	0.000171	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—lung cancer	3.14e-05	0.000165	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—lung cancer	3.02e-05	0.000159	CcSEcCtD
Etodolac—Rash—Doxorubicin—lung cancer	2.99e-05	0.000157	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—lung cancer	2.99e-05	0.000157	CcSEcCtD
Etodolac—Headache—Doxorubicin—lung cancer	2.97e-05	0.000156	CcSEcCtD
Etodolac—Nausea—Doxorubicin—lung cancer	2.82e-05	0.000148	CcSEcCtD
Etodolac—ALB—Hemostasis—EGF—lung cancer	8.84e-06	6.26e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CD—lung cancer	8.81e-06	6.24e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ERCC2—lung cancer	8.77e-06	6.21e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.74e-06	6.18e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOA1—lung cancer	8.71e-06	6.17e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTA4—lung cancer	8.71e-06	6.16e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—lung cancer	8.7e-06	6.16e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HRAS—lung cancer	8.64e-06	6.12e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALDOA—lung cancer	8.54e-06	6.04e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CG—lung cancer	8.52e-06	6.04e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	8.51e-06	6.03e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTA2—lung cancer	8.48e-06	6.01e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	8.48e-06	6.01e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.4e-06	5.94e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.34e-06	5.91e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CREBBP—lung cancer	8.29e-06	5.87e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NCOA3—lung cancer	8.29e-06	5.87e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTP1—lung cancer	8.28e-06	5.86e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—lung cancer	8.27e-06	5.85e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTA1—lung cancer	8.19e-06	5.8e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FOXO3—lung cancer	8.18e-06	5.79e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.14e-06	5.77e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—POMC—lung cancer	8.11e-06	5.75e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	8.11e-06	5.74e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCC3—lung cancer	8.09e-06	5.73e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ADCY1—lung cancer	8.06e-06	5.71e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCG2—lung cancer	8.06e-06	5.71e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CAT—lung cancer	8.05e-06	5.7e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.01e-06	5.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP2E1—lung cancer	7.97e-06	5.64e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CG—lung cancer	7.95e-06	5.63e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ENO2—lung cancer	7.91e-06	5.6e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—HPGDS—lung cancer	7.91e-06	5.6e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CREBBP—lung cancer	7.9e-06	5.6e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NQO1—lung cancer	7.88e-06	5.58e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CD—lung cancer	7.86e-06	5.57e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPP2R1B—lung cancer	7.86e-06	5.56e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C1—lung cancer	7.84e-06	5.55e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ABCB1—lung cancer	7.83e-06	5.55e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.75e-06	5.49e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.71e-06	5.46e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TYMS—lung cancer	7.69e-06	5.45e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CB—lung cancer	7.68e-06	5.44e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTT1—lung cancer	7.67e-06	5.43e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—lung cancer	7.63e-06	5.4e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—lung cancer	7.61e-06	5.39e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—UGT1A1—lung cancer	7.61e-06	5.39e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTM1—lung cancer	7.6e-06	5.38e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOA1—lung cancer	7.59e-06	5.37e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2A6—lung cancer	7.58e-06	5.37e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GCLC—lung cancer	7.58e-06	5.37e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—POMC—lung cancer	7.57e-06	5.36e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.55e-06	5.35e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CD—lung cancer	7.49e-06	5.31e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—lung cancer	7.4e-06	5.24e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CREBBP—lung cancer	7.37e-06	5.22e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GNG11—lung cancer	7.34e-06	5.2e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.3e-06	5.17e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.27e-06	5.14e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HES1—lung cancer	7.25e-06	5.13e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1A1—lung cancer	7.21e-06	5.1e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ENO1—lung cancer	7.19e-06	5.09e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	7.18e-06	5.08e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.16e-06	5.07e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ERCC2—lung cancer	7.15e-06	5.06e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—STK11—lung cancer	7.1e-06	5.03e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RAF1—lung cancer	7.02e-06	4.97e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CD—lung cancer	6.99e-06	4.95e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALDOA—lung cancer	6.99e-06	4.95e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CG—lung cancer	6.93e-06	4.9e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—lung cancer	6.9e-06	4.89e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CB—lung cancer	6.85e-06	4.85e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NCOA3—lung cancer	6.78e-06	4.8e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERCC2—lung cancer	6.78e-06	4.8e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.67e-06	4.72e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.66e-06	4.72e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—lung cancer	6.64e-06	4.7e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB3—lung cancer	6.63e-06	4.69e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	6.62e-06	4.69e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ADCY1—lung cancer	6.6e-06	4.67e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCG2—lung cancer	6.6e-06	4.67e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—POMC—lung cancer	6.59e-06	4.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTP1—lung cancer	6.57e-06	4.65e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CB—lung cancer	6.53e-06	4.62e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—lung cancer	6.47e-06	4.58e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HPGDS—lung cancer	6.47e-06	4.58e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ENO2—lung cancer	6.47e-06	4.58e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2E1—lung cancer	6.44e-06	4.56e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPP2R1B—lung cancer	6.43e-06	4.55e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CREBBP—lung cancer	6.42e-06	4.55e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CAT—lung cancer	6.39e-06	4.53e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NQO1—lung cancer	6.37e-06	4.51e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.36e-06	4.5e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TERT—lung cancer	6.35e-06	4.5e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.34e-06	4.49e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—EP300—lung cancer	6.33e-06	4.48e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—lung cancer	6.29e-06	4.46e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTT1—lung cancer	6.28e-06	4.44e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.24e-06	4.42e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ABCB1—lung cancer	6.22e-06	4.4e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2A6—lung cancer	6.2e-06	4.39e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GCLC—lung cancer	6.2e-06	4.39e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOA1—lung cancer	6.19e-06	4.38e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.18e-06	4.38e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.18e-06	4.38e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGFR1—lung cancer	6.17e-06	4.37e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TYMS—lung cancer	6.11e-06	4.32e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CB—lung cancer	6.09e-06	4.31e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CD—lung cancer	6.09e-06	4.31e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	6.08e-06	4.3e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HIF1A—lung cancer	6.08e-06	4.3e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTM1—lung cancer	6.04e-06	4.27e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—lung cancer	6.04e-06	4.27e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—lung cancer	6.01e-06	4.26e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.92e-06	4.19e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ENO1—lung cancer	5.88e-06	4.16e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOA1—lung cancer	5.86e-06	4.15e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.86e-06	4.15e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MAPK3—lung cancer	5.79e-06	4.1e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.78e-06	4.1e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—STK11—lung cancer	5.74e-06	4.07e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1A1—lung cancer	5.72e-06	4.05e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ERCC2—lung cancer	5.68e-06	4.02e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—EP300—lung cancer	5.65e-06	4e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CG—lung cancer	5.65e-06	4e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—lung cancer	5.64e-06	4e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—lung cancer	5.63e-06	3.98e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SRC—lung cancer	5.49e-06	3.89e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.39e-06	3.82e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—EP300—lung cancer	5.38e-06	3.81e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—POMC—lung cancer	5.37e-06	3.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APC—lung cancer	5.35e-06	3.79e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KIT—lung cancer	5.35e-06	3.79e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—lung cancer	5.35e-06	3.79e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTP1—lung cancer	5.31e-06	3.76e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CB—lung cancer	5.31e-06	3.76e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGF—lung cancer	5.29e-06	3.75e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NRAS—lung cancer	5.28e-06	3.74e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2E1—lung cancer	5.28e-06	3.74e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—lung cancer	5.26e-06	3.73e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—lung cancer	5.26e-06	3.72e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CREBBP—lung cancer	5.24e-06	3.71e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NQO1—lung cancer	5.22e-06	3.69e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CAT—lung cancer	5.17e-06	3.66e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.14e-06	3.64e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.11e-06	3.62e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.06e-06	3.58e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK3—lung cancer	5.06e-06	3.58e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—BRAF—lung cancer	5.03e-06	3.56e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCB1—lung cancer	5.03e-06	3.56e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—EP300—lung cancer	5.02e-06	3.56e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6R—lung cancer	4.97e-06	3.52e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CD—lung cancer	4.96e-06	3.51e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CREBBP—lung cancer	4.96e-06	3.51e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—TYMS—lung cancer	4.94e-06	3.5e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOA1—lung cancer	4.91e-06	3.48e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—lung cancer	4.9e-06	3.47e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTM1—lung cancer	4.88e-06	3.46e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAP2K1—lung cancer	4.74e-06	3.35e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CD—lung cancer	4.71e-06	3.33e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—STK11—lung cancer	4.7e-06	3.33e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.7e-06	3.33e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—lung cancer	4.68e-06	3.32e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1A1—lung cancer	4.63e-06	3.28e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ERCC2—lung cancer	4.59e-06	3.25e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—lung cancer	4.59e-06	3.25e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—lung cancer	4.55e-06	3.22e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CG—lung cancer	4.48e-06	3.17e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.41e-06	3.12e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—EP300—lung cancer	4.37e-06	3.1e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTP1—lung cancer	4.35e-06	3.08e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CB—lung cancer	4.33e-06	3.06e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—lung cancer	4.29e-06	3.04e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—POMC—lung cancer	4.27e-06	3.02e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CAT—lung cancer	4.23e-06	3e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MDM2—lung cancer	4.22e-06	2.98e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.21e-06	2.98e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—RAF1—lung cancer	4.2e-06	2.97e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—lung cancer	4.18e-06	2.96e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CREBBP—lung cancer	4.16e-06	2.94e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—lung cancer	4.16e-06	2.94e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCB1—lung cancer	4.12e-06	2.92e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CB—lung cancer	4.1e-06	2.9e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTOR—lung cancer	4.1e-06	2.9e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD4—lung cancer	4.09e-06	2.9e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TYMS—lung cancer	4.04e-06	2.86e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—lung cancer	4.04e-06	2.86e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTM1—lung cancer	4e-06	2.83e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—lung cancer	3.98e-06	2.82e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOA1—lung cancer	3.97e-06	2.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CD—lung cancer	3.94e-06	2.79e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—lung cancer	3.9e-06	2.76e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—lung cancer	3.89e-06	2.75e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HRAS—lung cancer	3.87e-06	2.74e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—lung cancer	3.83e-06	2.71e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.8e-06	2.69e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1A1—lung cancer	3.79e-06	2.68e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ERCC2—lung cancer	3.76e-06	2.66e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—lung cancer	3.74e-06	2.65e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—lung cancer	3.71e-06	2.63e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CG—lung cancer	3.63e-06	2.57e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—EP300—lung cancer	3.57e-06	2.52e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1A—lung cancer	3.55e-06	2.52e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—lung cancer	3.54e-06	2.51e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—POMC—lung cancer	3.45e-06	2.44e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CB—lung cancer	3.43e-06	2.43e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—lung cancer	3.41e-06	2.42e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EP300—lung cancer	3.38e-06	2.39e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CREBBP—lung cancer	3.36e-06	2.38e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SRC—lung cancer	3.29e-06	2.33e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—lung cancer	3.25e-06	2.3e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOA1—lung cancer	3.25e-06	2.3e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—lung cancer	3.24e-06	2.29e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CD—lung cancer	3.19e-06	2.26e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—lung cancer	3.17e-06	2.24e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NRAS—lung cancer	3.16e-06	2.24e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.11e-06	2.2e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—lung cancer	3.03e-06	2.15e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK3—lung cancer	3.03e-06	2.14e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CG—lung cancer	2.97e-06	2.1e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—lung cancer	2.97e-06	2.1e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—lung cancer	2.95e-06	2.09e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—lung cancer	2.88e-06	2.04e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—EP300—lung cancer	2.83e-06	2e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—POMC—lung cancer	2.83e-06	2e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CB—lung cancer	2.78e-06	1.97e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—lung cancer	2.75e-06	1.95e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CREBBP—lung cancer	2.75e-06	1.95e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—lung cancer	2.72e-06	1.93e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—lung cancer	2.64e-06	1.87e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—lung cancer	2.64e-06	1.87e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CD—lung cancer	2.61e-06	1.85e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—lung cancer	2.58e-06	1.82e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—lung cancer	2.5e-06	1.77e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—lung cancer	2.4e-06	1.7e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HRAS—lung cancer	2.31e-06	1.64e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—EP300—lung cancer	2.29e-06	1.62e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CB—lung cancer	2.27e-06	1.61e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—lung cancer	2.25e-06	1.6e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—lung cancer	2.21e-06	1.57e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—lung cancer	2.15e-06	1.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—lung cancer	2.09e-06	1.48e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—lung cancer	2.04e-06	1.45e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—lung cancer	1.97e-06	1.39e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—EP300—lung cancer	1.87e-06	1.33e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—lung cancer	1.71e-06	1.21e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—lung cancer	1.69e-06	1.2e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—lung cancer	1.39e-06	9.82e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—lung cancer	1.38e-06	9.8e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—lung cancer	1.13e-06	8.02e-06	CbGpPWpGaD
